V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10449506 | 10034106 | 1.68 | 81 | 03 | 2021-03-05 | 2021-03-16 | Docetaxel | 02 | N | DOCETAXEL | 100649923 |
| 10449513 | 10034107 | 1.78 | 71 | Not known (9) | 2015-07-16 | 2015-07-24 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 100855576 |
| 10449552 | 10034108 | 1.58 | 67.4 | Curative (C) | 2018-11-18 | 2018-12-09 | CAPECITABINE + RT | N | N | CAPECITABINE | 101264538 |
| 10449554 | 10034109 | 1.6 | 63.95 | Palliative (P) | 2019-04-30 | 2019-05-01 | Rituximab | 02 | null | RITUXIMAB | 101736749 |
| 10449589 | 10034110 | null | 62.8 | null | 2021-01-22 | 2021-02-03 | Capecitabine + Oxaliplatin 21day | null | null | CAPECITABINE | 100327999 |
| 10449615 | 10034111 | 1.58 | 67.5 | 03 | 2017-06-26 | 2017-07-05 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101672164 |
| 10449634 | 10034112 | 1.54 | 86 | null | 2021-12-16 | 2021-12-23 | IBRUTINIB | 02 | null | IBRUTINIB | 100498148 |
| 10449643 | 10034113 | 1.58 | 84.2 | null | 2021-09-27 | 2021-10-09 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101053816 |
| 10449651 | 10034114 | 1.58 | 69 | Palliative (P) | 2019-01-08 | 2019-02-02 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101791544 |
| 10449655 | 10034115 | 1.59 | 68.4 | null | 2019-10-16 | 2019-10-17 | Capecitabine | 02 | N | CAPECITABINE | 100105168 |
| 10449689 | 10034116 | 1.58 | 0 | Adjuvant (A) | 2018-09-09 | 2018-09-10 | CAPECITABINE + OXALIPLATIN | 99 | null | IBRUTINIB | 100955563 |
| 10449690 | 10034117 | 1.85 | 71.4 | Curative (C) | 2017-11-16 | 2017-11-16 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101713943 |
| 10449731 | 10034118 | 1.74 | null | 03 | 2017-03-23 | 2017-04-21 | IBRUTINIB | 02 | N | IBRUTINIB | 101338386 |
| 10449740 | 10034119 | null | 100 | null | 2018-11-26 | 2018-12-03 | IBRUTINIB | 02 | null | IBRUTINIB | 101826657 |
| 10449781 | 10034120 | 1.9 | 64.2 | Palliative (P) | 2018-10-29 | 2018-10-29 | Capecitabine 5days + RT | 02 | N | CAPECITABINE | 100365650 |
| 10449786 | 10034121 | 1.64 | 57.8 | Neo-adjuvant (N) | 2019-07-28 | 2019-08-25 | IBRUTINIB | 02 | null | IBRUTINIB | 101385802 |
| 10449790 | 10034122 | 1.67 | 58.5 | Curative (C) | 2017-12-05 | 2017-12-06 | DOCETAXEL + Prednisolone | 02 | N | DOCETAXEL | 100604921 |
| 10449825 | 10034123 | 1.62 | 82 | 03 | 2017-04-17 | 2017-09-23 | Capecitabine | 02 | N | CAPECITABINE | 101792308 |
| 10449852 | 10034124 | 1.7 | 116 | Adjuvant (A) | 2018-03-08 | 2018-04-19 | Rituximab | 02 | N | RITUXIMAB | 100855201 |
| 10449868 | 10034125 | 1.82 | 68.5 | Curative (C) | 2019-04-29 | 2019-05-12 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 101107732 |
| 10449872 | 10034126 | 1.69 | 90.3 | Palliative (P) | 2016-06-29 | 2016-06-29 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100262480 |
| 10449882 | 10034127 | 1.69 | 74.3 | Curative (C) | 2020-08-08 | 2020-08-21 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 101105414 |
| 10449892 | 10034128 | 1.62 | 85.8 | null | 2021-08-13 | 2021-08-14 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100976122 |
| 10449894 | 10034129 | 1.57 | 81 | null | 2021-08-21 | 2021-09-09 | Docetaxel | 02 | null | DOCETAXEL | 100238104 |
| 10449913 | 10034130 | 1.75 | 101.9 | Palliative (P) | 2015-05-07 | 2015-05-07 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101738961 |
| 10449920 | 10034131 | 1.8 | 74 | Palliative (P) | 2019-11-04 | 2019-11-10 | CAPECITABINE + OXALIPLATIN | 02 | N | DOCETAXEL | 100041532 |
| 10449921 | 10034132 | 1.73 | 76.6 | Disease modification (D) | 2018-01-20 | 2018-01-20 | PEMBROLIZUMAB | 2 | N | PEMBROLIZUMAB | 100047655 |
| 10449923 | 10034133 | 1.73 | 71.8 | Curative (C) | 2021-03-03 | 2021-03-03 | Capecitabine 5days + RT | 02 | N | CAPECITABINE | 101717849 |
| 10449934 | 10034134 | 1.71 | 65 | Neo-adjuvant (N) | 2021-07-01 | 2021-07-10 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101017481 |
| 10449970 | 10034135 | 1.72 | 75 | null | 2021-03-31 | 2021-04-04 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 100724586 |
| 10449976 | 10034136 | 1.55 | 60.1 | Curative (C) | 2018-10-05 | 2019-01-18 | IBRUTINIB | N | N | IBRUTINIB | 100227283 |
| 10449994 | 10034137 | 1.85 | 69.8 | Neo-adjuvant (N) | 2016-07-07 | 2016-07-12 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100038371 |
| 10449996 | 10034138 | 1.78 | 89 | Disease modification (D) | 2017-03-27 | 2017-04-10 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101327081 |
| 10450007 | 10034139 | 1.71 | 58.4 | Palliative (P) | 2017-06-01 | 2017-06-15 | Docetaxel | N | N | DOCETAXEL | 100596387 |
| 10450022 | 10034140 | 1.73 | 77.3 | null | 2020-01-12 | 2020-01-16 | IBRUTINIB | 02 | null | IBRUTINIB | 100541724 |
| 10450071 | 10034141 | 1.74 | 56.2 | Palliative (P) | 2016-02-15 | 2016-02-16 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101619437 |
| 10450076 | 10034142 | 1.74 | 73.6 | Adjuvant (A) | 2021-07-08 | 2021-07-26 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101173521 |
| 10450114 | 10034143 | 1.52 | 57.4 | 03 | 2018-10-16 | 2018-10-16 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100888745 |
| 10450121 | 10034144 | 1.55 | 84 | Adjuvant (A) | 2017-09-18 | 2017-09-24 | Capecitabine | 02 | N | CAPECITABINE | 100547518 |
| 10450123 | 10034145 | 1.7 | 65 | Disease modification (D) | 2016-12-25 | 2017-01-29 | Capecitabine 35days + RT | 02 | null | CAPECITABINE | 100558082 |
| 10450131 | 10034146 | 1.85 | 0 | Palliative (P) | 2018-08-16 | 2018-08-16 | Rituximab | 02 | N | RITUXIMAB | 100967607 |
| 10450148 | 10034147 | 1.74 | null | Neo-adjuvant (N) | 2017-07-26 | 2017-08-14 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101602902 |
| 10450152 | 10034148 | 1.57 | 77 | null | 2021-10-04 | 2021-10-23 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 101636286 |
| 10450201 | 10034149 | 1.75 | 91.6 | Palliative (P) | 2016-02-12 | 2016-03-10 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101131561 |
| 10450203 | 10034150 | 1.65 | 100.2 | null | 2021-11-12 | 2021-11-12 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | null | RITUXIMAB | 100893401 |
| 10450234 | 10034151 | 1.69 | 79.8 | null | 2021-07-15 | 2021-07-29 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101760264 |
| 10450236 | 10034152 | 1.63 | 71 | Palliative (P) | 2016-07-22 | 2016-07-28 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101196517 |
| 10450254 | 10034153 | 1.79 | 52.2 | Palliative (P) | 2018-10-08 | 2018-10-08 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101590820 |
| 10450268 | 10034154 | 1.83 | 84 | null | 2022-03-08 | 2022-03-12 | Rituximab | 02 | null | RITUXIMAB | 100645908 |
| 10450280 | 10034155 | null | 69.1 | null | 2021-06-18 | 2021-07-09 | PEMBROLIZUMAB | 99 | null | PEMBROLIZUMAB | 100290607 |